Home  /  Resource Library  /  Ibrutinib Combo New Standard for Transplant-Ineligible Mantle Cell Lymphoma in Older Patients

Ibrutinib Combo New Standard for Transplant-Ineligible Mantle Cell Lymphoma in Older Patients

ASCO 2022